Production of mevalonate, isoprene, and isoprenoids using genes encoding polypeptides having thiolase, HMG-CoA synthase and HMG-CoA reductase enzymatic activities

US9752162B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9752162-B2
Application numberUS-201414514962-A
CountryUS
Kind codeB2
Filing dateOct 15, 2014
Priority dateApr 29, 2011
Publication dateSep 5, 2017
Grant dateSep 5, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention features compositions and methods for the increased production of mevalonate, isoprene, isoprenoid precursor molecules, and/or isoprenoids in microorganisms via the heterologous expression of the mvaE and mvaS genes from the organisms Listeria grayi DSM 20601, Enterococcus faecium, Enterococcus gallinarum EG2, and Enterococcus casseliflavus.

First claim

Opening claim text (preview).

What is claimed is: 1. Recombinant cells with increased production of isoprene, the cells comprising one or more heterologous nucleic acids comprising a mevalonate E (mvaE) gene and a mevalonate S (mvaS) gene selected from the organisms Listeria grayi ( L. grayi ), Enterococcus faecium ( E. faecium ), Enterococcus gallinarum ( E. gallinarum ), and Enterococcus casseliflavus ( E. casseliflavus ), wherein the mvaE gene and the mvaS gene encode polypeptides having thiolase, HMG-CoA synthase, and HMG-CoA reductase catalytic activities, and wherein the cells further comprise: i. one or more nucleic acids encoding polypeptides of the lower MVA pathway; and ii. a heterologous nucleic acid encoding an isoprene synthase polypeptide, wherein the cells produce increased amounts of isoprene compared to isoprene-producing cells that do not comprise the mvaE gene and the mvaS gene. 2. The cells of claim 1 , wherein the mvaE gene and mvaS gene are from different organisms. 3. The cells of claim 1 , wherein: a) the mvaE gene is from L. grayi and the mvaS gene is from E. faecium; b) the mvaE gene is from L. grayi and the mvaS gene is from E. gallinarum; c) the mvaE gene is from L. grayi and the mvaS gene is from E. casseliflavus; d) the mvaE gene is from E. faecium and the mvaS gene is from L. grayi; e) the mvaE gene is from E. faecium and the mvaS gene is from E. gallinarum; f) the mvaE gene is from E. faecium and the mvaS gene is from E. casseliflavus; g) the mvaE gene is from E. gallinarum and the mvaS gene is from L. grayi; h) the mvaE gene is from E. gallinarum and the mvaS gene is from E. faecium; i) the mvaE gene is from E. gallinarum and the mvaS gene is from E. casseliflavus; j) the mvaE gene is from E. casseliflavus and the mvaS gene is from L. grayi; k) the mvaE gene is from E. casseliflavus and the mvaS gene is from E. faecium ; or l) the mvaE gene is from E. casseliflavus and the mvaS gene is from E. gallinarum. 4. The cells of claim 1 , wherein the cells produce increased amounts of isoprene compared to isoprene-producing cells that (A) contain a mvaE gene from Enterococcus faecalis and (B) do not contain the mvaE gene and the mvaS gene from L. grayi, E. faecium, E. gallinarum , or E. casseliflavus. 5. The cells of claim 1 , wherein the nucleic acids encoding polypeptides of the lower MVA pathway comprise enzymes selected from: (a) an enzyme that phosphorylates mevalonate to mevalonate 5-phosphate; (b) an enzyme that converts mevalonate 5-phosphate to mevalonate 5-pyrophosphate; and (c) an enzyme that converts mevalonate 5-pyrophosphate to isopentenyl pyrophosphate. 6. The cells of claim 5 , wherein the enzyme that phosphorylates mevalonate to mevalonate 5-phosphate is selected from the group consisting of M. mazei mevalonate kinase, M. burtonii mevalonate kinase polypeptide, Lactobacillus mevalonate kinase polypeptide, Lactobacillus sakei mevalonate kinase polypeptide, yeast mevalonate kinase polypeptide, Saccharomyces cerevisiae mevalonate kinase polypeptide, Streptococcus mevalonate kinase polypeptide, Streptococcus pneumoniae mevalonate kinase polypeptide, Streptomyces mevalonate kinase polypeptide, and Streptomyces CL190 mevalonate kinase polypeptide. 7. The cells of claim 1 , wherein the isoprene synthase polypeptide is a plant isoprene synthase polypeptide or a variant thereof. 8. The cells of claim 7 , wherein the isoprene synthase polypeptide is a polypeptide from Pueraria or Populus or a hybrid, Populus alba x Populus tremula , or a variant thereof. 9. The cells of claim 7 , wherein the plant isoprene synthase polypeptide is a Populus alba isoprene synthase polypeptide. 10. The cells of claim 1 , further comprising one or more nucleic acids encoding an isopentenyl-diphosphate delta-isomerase (IDI) polypeptide. 11. The cells of claim 1 , wherein any one or more nucleic acids is placed under an inducible promoter or a constitutive promoter. 12. The cells of claim 1 , wherein any one or more nucleic acids is cloned into a multicopy plasmid. 13. The cells of claim 1 , wherein any one or more nucleic acids is integrated into a chromosome of the cells. 14. The cells of claim 1 , wherein the cells are gram-positive bacterial cells, gram-negative bacterial cells, Escherichia cells, Pantoea cells, fungal cells, filamentous fungal cells, Trichoderma cells, Aspergillus cells, or yeast cells. 15. The cells of claim 14 , wherein the cells are selected from the group consisting of E. coli, P. citrea, B. subtilis, B. licheniformis, B. lentus, B. brevis, B. stearothermophilus, B. alkalophilus, B. amyloliquefaciens, B. clausii, B. halodurans, B. megaterium, B. coagulans, B. circulans, B. lautus, B. thuringiensis, S. albus, S. lividans, S. coelicolor, S. griseus, Pseudomonas sp., and P. alcaligenes cells. 16. The cells of claim 15 , wherein the cells are E. coli cells. 17. The cells of claim 14 , wherein the cells are yeast cells. 18. The cells of claim 17 , wherein the yeast cells are selected from the group consisting of Saccharomyces sp., Schizosaccharomyces sp., Pichia sp., and Candida sp. cells. 19. The cells of claim 18 , wherein the yeast cells are Saccharomyces cerevisiae cells. 20. A method of producing isoprene, comprising: (a) culturing the host cells of claim 1 under suitable culture conditions for the production of isoprene; and (b) producing the isoprene. 21. The method of claim 20 , further comprising (c) recovering the isoprene.

Assignees

Inventors

Classifications

  • Acyltransferases (2.3) · CPC title

  • for yeasts · CPC title

  • cyclic (compounds containing at least three condensed carbocyclic rings C12P15/00) · CPC title

  • C12P5/007Primary

    containing one or more isoprene units, i.e. terpenes (carotenes C12P23/00) · CPC title

  • Acetyl-CoA C-acyltransferase (2.3.1.16) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9752162B2 cover?
The invention features compositions and methods for the increased production of mevalonate, isoprene, isoprenoid precursor molecules, and/or isoprenoids in microorganisms via the heterologous expression of the mvaE and mvaS genes from the organisms Listeria grayi DSM 20601, Enterococcus faecium, Enterococcus gallinarum EG2, and Enterococcus casseliflavus.
Who is the assignee on this patent?
Danisco Us Inc, Goodyear Tire & Rubber
What technology area does this patent fall under?
Primary CPC classification C12P5/007. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Sep 05 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).